{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:07:08Z","timestamp":1785852428956,"version":"3.56.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>\n                    <jats:sup>68<\/jats:sup>\n                    Ga-Trivehexin is a novel PET tracer targeting the \u03b1v\u03b26 integrin receptor, which is involved in cell adhesion, migration, and epithelial-mesenchymal transition. The physiological distribution of this tracer remains under investigation, as \u03b1v\u03b26 expression is mainly confined to epithelial cells undergoing regeneration or neoplastic transformation. Hence, unexpected uptake in nonepithelial tissues may constitute a diagnostic pitfall. We report a case of\n                    <jats:sup>68<\/jats:sup>\n                    Ga-Trivehexin uptake in the pituitary gland without any corresponding abnormality on CT or MRI. This observation highlights the need for careful molecular and morphologic correlation to distinguish physiological from pathologic tracer uptake.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006266","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T15:00:33Z","timestamp":1766502033000},"page":"e726-e727","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Focal 68Ga-Trivehexin Uptake in a Normal Pituitary Gland"],"prefix":"10.1097","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3984-9215","authenticated-orcid":false,"given":"Begum","family":"Arca","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine Goknur","family":"Isik","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilara","family":"Denizmen Zorba","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Barburoglu","sequence":"additional","affiliation":[{"name":"Radiology, Istanbul Faculty of Medicine, Istanbul University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Sanli","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"R1-20260702","first-page":"468","article-title":"Validation of in-house kit-like synthesis of 68GaTrivehexin and its biodistribution for targeting the integrin \u03b1v\u03b26 expressing tumors","volume":"38","author":"Thakral","year":"2023","journal-title":"Cancer Biother Radiopharm"},{"key":"R2-20260702","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/cancers17091504","article-title":"68Ga-Trivehexin: current status of \u03b1v\u03b26-integrin imaging and perspectives","volume":"17","author":"Urso","year":"2025","journal-title":"Cancers (Basel)"},{"key":"R3-20260702","doi-asserted-by":"crossref","first-page":"1487602","DOI":"10.3389\/fnume.2024.1487602","article-title":"\u03b1v\u03b26-integrin targeted PET\/CT imaging in pancreatic cancer patients using 68Ga-Trivehexin","volume":"4","author":"Rehm","year":"2024","journal-title":"Front Nucl Med"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s00259-021-05559-x","article-title":"PET\/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the \u201cCancer Integrin\u201d \u03b1v\u03b26 with Ga-68-Trivehexin","volume":"49","author":"Quigley","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R5-20260702","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1097\/RLU.0000000000005582","article-title":"Cancer integrin imaging with 68 Ga-Trivehexin PET-CT in head and neck squamous cell carcinoma improves diagnostic accuracy","volume":"50","author":"Emerson","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R6-20260702","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/RLU.0000000000005406","article-title":"68 Ga-Trivehexin PET\/CT in metastatic non-small cell lung cancer to the brain","volume":"49","author":"Marafi","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R7-20260702","article-title":"Triple negative breast cancer and 68Ga-Trivehexin: a glance of hope","author":"Marafi","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R8-20260702","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1007\/s00259-024-06846-z","article-title":"68Ga-Trivehexin PET\/CT: a promising novel tracer for primary hyperparathyroidism","volume":"51","author":"Kuyumcu","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-20260702","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1097\/RLU.0000000000005735","article-title":"Detection of recurrent parathyroid cancer using 68 Ga-Trivehexin PET\/CT","volume":"50","author":"Denizmen","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R10-20260702","doi-asserted-by":"crossref","first-page":"e717","DOI":"10.1097\/RLU.0000000000005950","article-title":"\u03b1v\u03b26 imaging with 68Ga-Trivehexin PET\/CT in pituitary macroadenoma","volume":"50","author":"Sadeq","year":"2025","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:43:13Z","timestamp":1785850993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006266"}},"subtitle":["Expanding the Spectrum of \u03b1v\u03b26-integrin PET Findings"],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006266","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"2025-11-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}